Cargando…

Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017

OBJECTIVE: Combination antiretroviral therapy (cART) has markedly increased survival and quality of life in people living with HIV. With the advent of new treatment options, including single-tablet regimens, durability and efficacy of first-line cART regimens are evolving. METHODS: We analyzed data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stecher, Melanie, Schommers, Philipp, Kollan, Christian, Stoll, Matthias, Kuhlendahl, Frieder, Stellbrink, Hans-Jürgen, Wasmuth, Jan-Christian, Stephan, Christoph, Hamacher, Laura, Lehmann, Clara, Boesecke, Christoph, Bogner, Johannes, Esser, Stefan, Fritzsche, Carlos, Haberl, Annette, Schürmann, Dirk, Degen, Olaf, Horst, Heinz-August, Hoffmann, Christian, Jensen, Björn, Schwarze-Zander, Carolynne, Platten, Martin, Fätkenheuer, Gerd, Schmidt, Daniel, Gunsenheimer-Bartmeyer, Barbara, Vehreschild, Jörg Janne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519003/ https://www.ncbi.nlm.nih.gov/pubmed/32613529 http://dx.doi.org/10.1007/s15010-020-01469-6

Ejemplares similares

Correction to: Treatment modifcation after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017
por: Stecher, Melanie, et al.
Publicado: (2021)

580. Key Factors for Treatment Changes Within 1 Year After Starting ART in the German ClinSurv Cohort: Between 2005 and 2014
por: Stecher, Melanie, et al.
Publicado: (2018)

Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors
por: Karo, Basel, et al.
Publicado: (2014)

Calculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort
por: Stoll, Matthias, et al.
Publicado: (2011)

CD4-cell counts and presence of AIDS in HIV-positive patients entering specialized care—a comparison of migrant groups in the German ClinSurv HIV Cohort Study, 1999–2013
por: Zeitlmann, Nadine, et al.
Publicado: (2016)

HIV-Prevalence in Tuberculosis Patients in Germany, 2002–2009: An Estimation Based on HIV and Tuberculosis Surveillance Data
por: Fiebig, Lena, et al.
Publicado: (2012)

Estimating Trends in the Proportion of Transmitted and Acquired HIV Drug Resistance in a Long Term Observational Cohort in Germany
por: Schmidt, Daniel, et al.
Publicado: (2014)

Implementation of EACS vaccination recommendations among people living with HIV
por: Breitschwerdt, Sven, et al.
Publicado: (2022)

Liver Fibrosis in HIV Patients Receiving a Modern cART: Which Factors Play a Role?
por: Mohr, Raphael, et al.
Publicado: (2015)

Moderate endurance training (marathon-training) – effects on immunologic and metabolic parameters in HIV-infected patients: the 42 KM cologne project
por: Schlabe, Stefan, et al.
Publicado: (2017)

Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis
por: Mohr, Raphael, et al.
Publicado: (2018)

Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)
por: Bischoff, Jenny, et al.
Publicado: (2021)

1280. Geospatial Spread of HIV in the Cologne-Bonn Region, Germany: From 2001 to 2016
por: Stecher, Melanie, et al.
Publicado: (2018)

1269. Cohort Profile: The Translational Platform HIV (TP-HIV), a Multicenter Cohort Project in Germany
por: Stecher, Melanie, et al.
Publicado: (2019)

Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART)
por: Dold, Leona, et al.
Publicado: (2015)

1283. Pretreatment HIV-1 Drug Resistance in Transmission Clusters of the Cologne-Bonn Region, Germany
por: Stecher, Melanie, et al.
Publicado: (2018)

Impact of COVID‐19 on HIV late diagnosis in a specialized German centre
por: van Bremen, Kathrin, et al.
Publicado: (2022)

Molecular Epidemiology of the HIV Epidemic in Three German Metropolitan Regions – Cologne/Bonn, Munich and Hannover, 1999–2016
por: Stecher, Melanie, et al.
Publicado: (2018)

1767. Structured Treatment Interruptions in HIV-Infected Patients Receiving Antiretroviral Therapy—Implications for Future HIV Cure Trials: A Systematic Review and Meta-analysis
por: Stecher, Melanie, et al.
Publicado: (2018)

Optimization of HIV testing services in Germany using HIV indicator diseases: study protocol of the HeLP study
por: Valbert, Frederik, et al.
Publicado: (2023)

From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany
por: Schmidt, Daniel, et al.
Publicado: (2015)

Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058
por: van de Vijver, David A M C, et al.
Publicado: (2019)

Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART)
por: Dold, Leona, et al.
Publicado: (2017)

Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIV
por: Dold, Leona, et al.
Publicado: (2023)

Everything counts - a method to determine viral suppression among people living with HIV using longitudinal data for the HIV care continuum - results of two large, German, multi-center real-life cohort studies over 20 years (1999–2018)
por: Schmidt, Daniel, et al.
Publicado: (2021)

Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients
por: Anadol, Evrim, et al.
Publicado: (2018)

Wie wirken Generikaquoten? Eine Analyse am Beispiel der HIV-Infektion
por: Rüsenberg, Robin, et al.
Publicado: (2021)

Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART
por: Dold, Leona, et al.
Publicado: (2019)

Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study
por: Schommers, Philipp, et al.
Publicado: (2018)

Using relative survival measures for cross-sectional and longitudinal benchmarks of countries, states, and districts: the BenchRelSurv- and BenchRelSurvPlot-macros
por: Jacke, Christian O, et al.
Publicado: (2013)

Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort
por: Bartmeyer, Barbara, et al.
Publicado: (2010)

Alterations of the NK cell pool in HIV/HCV co-infection
por: Kaczmarek, Dominik J., et al.
Publicado: (2017)

Severe monkeypox-virus infection in undiagnosed advanced HIV infection
por: Boesecke, Christoph, et al.
Publicado: (2022)

Factors associated with the informal use of HIV pre‐exposure prophylaxis in Germany: a cross‐sectional study
por: Koppe, Uwe, et al.
Publicado: (2019)

HIV, STI and renal function testing frequency and STI history among current users of self-funded HIV pre-exposure prophylaxis, a cross-sectional study, Germany, 2018 and 2019
por: Koppe, Uwe, et al.
Publicado: (2022)

Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany
por: Schmidt, Daniel, et al.
Publicado: (2022)

HPV-associated anal lesions in HIV+ patients: long-term results regarding quality of life
por: Wesselmann, Paul, et al.
Publicado: (2020)

Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany
por: Koppe, Uwe, et al.
Publicado: (2021)

Drug Resistance Spread in 6 Metropolitan Regions, Germany, 2001–2018
por: Stecher, Melanie, et al.
Publicado: (2020)

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort
por: Machnowska, Patrycja, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_inepuf8ioddnki9t0hcpmmra68